{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:12:19Z","timestamp":1778749939156,"version":"3.51.4"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prp.2026.156486","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:01:36Z","timestamp":1776873696000},"page":"156486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Opioids and cancer biology: Exploring the dark side of pain relief"],"prefix":"10.1016","volume":"283","author":[{"given":"Freshteh","family":"Haerifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Kalarestaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadmahdi","family":"Bahramloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Alinejad-Shahabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arian","family":"Samimifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyyede Sepide","family":"Ashraf Moosavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijeh","family":"Dizaji Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Mazloumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-2906","authenticated-orcid":false,"given":"Ali","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.prp.2026.156486_bib1","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cancers15030591","article-title":"Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis","volume":"15","author":"Snijders","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156486_bib3","series-title":"StatPearls [Internet]","article-title":"WHO analgesic ladder","author":"Anekar","year":"2023"},{"key":"10.1016\/j.prp.2026.156486_bib4","series-title":"Progress in Ensuring Adequate Access to Internationally Controlled Substances for Medical and Scientific Purposes: Supplement to the Report of the Board for 2018","author":"Board","year":"2019"},{"key":"10.1016\/j.prp.2026.156486_bib5","article-title":"Time to act for reappraising the educational system for universal access to opioid analgesics, for quality palliative care and cancer-related pain relief in East Asian countries","volume":"16","author":"Sumitani","year":"2021","journal-title":"Lancet Reg. Health West. Pac."},{"issue":"22","key":"10.1016\/j.prp.2026.156486_bib6","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.3390\/cancers14225720","article-title":"Effect of opioids on survival in patients with cancer","volume":"14","author":"Boland","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11864-020-0713-7","article-title":"Opioids and cancer mortality","volume":"21","author":"Amaram-Davila","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156486_bib8","first-page":"1695","article-title":"Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand","volume":"56","author":"Campa","year":"1996","journal-title":"Cancer Res"},{"issue":"3-4","key":"10.1016\/j.prp.2026.156486_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:CANC.0000031773.46458.63","article-title":"Opioid peptides in cancer","volume":"23","author":"Fichna","year":"2004","journal-title":"Cancer Metastas. Rev."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib10","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12560","article-title":"Opioids in cancer: the \u03ba\u2011opioid receptor (Review).","volume":"25","author":"Zhou","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"3 Pt 2","key":"10.1016\/j.prp.2026.156486_bib11","first-page":"R511","article-title":"Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture","volume":"271","author":"Zagon","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/1097-0142(19860215)57:4<769::AID-CNCR2820570415>3.0.CO;2-J","article-title":"Small cell carcinoma cell lines contain opioid peptides and receptors","volume":"57","author":"Roth","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib13","first-page":"418","article-title":"Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line","volume":"80","author":"Hatzoglou","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3835(94)90347-6","article-title":"Expression of opioid peptides in cells and stroma of human breast cancer and adenofibromas","volume":"77","author":"Chatikhine","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156486_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.792290","article-title":"Opioid receptor-mediated and non-opioid receptor-mediated roles of opioids in tumour growth and metastasis","volume":"11","author":"Scroope","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bja.2020.10.021","article-title":"Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer","volume":"126","author":"Montagna","year":"2021","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib17","first-page":"207","article-title":"Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients","volume":"48","author":"Madar","year":"2007","journal-title":"J. Nucl. Med"},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib18","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.3892\/or.2016.5109","article-title":"Upregulation and activation of \u03b4\u2011opioid receptors promotes the progression of human breast cancer","volume":"36","author":"Wei","year":"2016","journal-title":"Oncol. Rep."},{"issue":"3a","key":"10.1016\/j.prp.2026.156486_bib19","first-page":"1787","article-title":"Molecular characterization of the human delta opioid receptor in lung cancer","volume":"18","author":"Schreiber","year":"1998","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib20","article-title":"Network-based analysis of microRNAs targeting the RAS\/MAPK signaling pathway in colorectal cancer","volume":"12","author":"Azimi","year":"2025","journal-title":"Immunopathol. Persa"},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib21","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.humpath.2012.11.025","article-title":"\u03ba-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma","volume":"44","author":"Zhang","year":"2013","journal-title":"Hum. Pathol."},{"issue":"23","key":"10.1016\/j.prp.2026.156486_bib22","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.28345","article-title":"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer","volume":"119","author":"Zylla","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bja.2020.07.051","article-title":"Increased mu-opioid receptor expression is associated with reduced disease-free and overall survival in laryngeal squamous cell carcinoma","volume":"125","author":"Zhang","year":"2020","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib24","first-page":"421","article-title":"Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck","volume":"19","author":"McLaughlin","year":"2007","journal-title":"Int J. Mol. Med"},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept Signal Transduct. Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/abbs\/gmt118","article-title":"MOR promotes epithelial-mesenchymal transition and proliferation via PI3K\/AKT signaling pathway in human colorectal cancer: MOR promotes EMT and proliferation","volume":"55","author":"Gao","year":"2023","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1213\/ANE.0b013e31820568af","article-title":"The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation","volume":"112","author":"Mathew","year":"2011","journal-title":"Anesth. & Analg."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/ALN.0b013e31824babe2","article-title":"Overexpression of the \u03bc-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis","volume":"116","author":"Lennon","year":"2012","journal-title":"J. Am. Soc. Anesthesiol."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0006-291X(03)00792-7","article-title":"Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells","volume":"305","author":"Yang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib32","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.21037\/jgo-20-394","article-title":"Morphine promotes angiogenesis by activating PI3K\/Akt\/HIF-1\u03b1 pathway and upregulating VEGF in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"issue":"15","key":"10.1016\/j.prp.2026.156486_bib35","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0b013e31824b9512","article-title":"The \u03bc-opioid receptor in cancer progression: is there a direct effect?","volume":"116","author":"Lennon","year":"2012","journal-title":"J. Am. Soc. Anesthesiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib37","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/srep03213","article-title":"\u043a Opioids inhibit tumor angiogenesis by suppressing VEGF signaling","volume":"3","author":"Yamamizu","year":"2013","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091577","article-title":"The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer","volume":"9","author":"Lennon","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2026.156486_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113910","article-title":"Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform","volume":"177","author":"Vasudevan","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.prp.2026.156486_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/bs.pmbts.2022.06.017","article-title":"Paul, B., S. Sribhashyam, and S. Majumdar, Opioid signaling and design of analgesics.","volume":"195","year":"2023","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bph.12573","article-title":"\u03ba Opioid receptor ligands regulate angiogenesis in development and in tumours","volume":"172","author":"Yamamizu","year":"2015","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.prp.2026.156486_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2021.110568","article-title":"The kappa opioid receptor may be a potential tumor suppressor by regulating angiogenesis in breast cancer","volume":"150","author":"Shi","year":"2021","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib43","first-page":"109","article-title":"Opioids and cancer: friend or foe? Curr Opin Support","volume":"10","author":"Wigmore","year":"2016","journal-title":"Palliat. Care"},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jpain.2018.01.002","article-title":"A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain","volume":"19","author":"Edwards","year":"2018","journal-title":"J. Pain."},{"key":"10.1016\/j.prp.2026.156486_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/164_2021_441","article-title":"Kappa Opioid Receptor Expression and Function in Cells of the Immune System","volume":"271","author":"Rogers","year":"2022","journal-title":"Handb. Exp. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010315","article-title":"Expression of Opioid Receptors in Cells of the Immune System","volume":"22","author":"Brejchova","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib47","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(24)37425-7","article-title":"delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception","volume":"285","author":"S\u00e1nchez-Bl\u00e1zquez","year":"1998","journal-title":"J. Pharm. Exp. Ther."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.5483\/BMBRep.2016.49.11.133","article-title":"GPR78 promotes lung cancer cell migration and metastasis by activation of G\u03b1q-Rho GTPase pathway","volume":"49","author":"Dong","year":"2016","journal-title":"BMB Rep."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neo.2020.12.011","article-title":"Opioids drive breast cancer metastasis through the \u03b4-opioid receptor and oncogenic STAT3","volume":"23","author":"Tripolt","year":"2021","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib50","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00210-018-1565-6","article-title":"Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms","volume":"391","author":"Brinkman","year":"2018","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib51","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/sj.bjc.6604057","article-title":"COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia","volume":"97","author":"Farooqui","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib52","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbadis.2014.01.003","article-title":"Morphine modulates cell proliferation through mir133b & mir128 in the neuroblastoma SH-SY5Y cell line","volume":"1842","author":"Gonzalez-Nunez","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib53","article-title":"The role of morphine in animal models of human cancer: does morphine promote or inhibit the tumor growth?","volume":"2013","author":"Bimonte","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.prp.2026.156486_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-021-01475-7","article-title":"Comparative analysis of the effects of opioids in angiogenesis","volume":"21","author":"Feng","year":"2021","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.prp.2026.156486_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-019-0699-1","article-title":"Opioids in cancer development, progression and metastasis: focus on colorectal cancer","volume":"21","author":"Szczepaniak","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/eujp.2001.0292","article-title":"Advancement of opioid analgesia with controlled-release oxycodone","volume":"5","author":"Levy","year":"2001","journal-title":"Eur. J. Pain."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archinte.166.8.837","article-title":"Oxycodone for Cancer-Related Pain: Meta-analysis of Randomized Controlled Trials","volume":"166","author":"Reid","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.prp.2026.156486_bib58","series-title":"Modulation of mu-opioid receptor dynamics at the plasma membrane and its implications for signalling and trafficking","author":"Underwood","year":"2023"},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib59","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1476-5381.1993.tb12882.x","article-title":"Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro","volume":"108","author":"Driessen","year":"1993","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1996.tb00152.x","article-title":"Contribution of monoaminergic modulation to the analgesic effect of tramadol","volume":"41","author":"Desmeules","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.prp.2026.156486_bib61","article-title":"Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/tbcr-23-6","article-title":"The association between perioperative opioids and breast cancer recurrence: a narrative review of the literature","volume":"4","author":"Thomas","year":"2023","journal-title":"Transl. Breast Cancer Res"},{"issue":"12","key":"10.1016\/j.prp.2026.156486_bib63","article-title":"Tramadol regulates proliferation, migration and invasion via PTEN\/PI3K\/AKT signaling in lung adenocarcinoma cells","volume":"20","author":"Xia","year":"2016","journal-title":"Eur. Rev. Med. & Pharmacol. Sci."},{"issue":"2S","key":"10.1016\/j.prp.2026.156486_bib64","doi-asserted-by":"crossref","first-page":"SE11","DOI":"10.36076\/ppj.2017.sE21","article-title":"Opioids inhibit angiogenesis in a chorioallantoic membrane model","volume":"20","author":"Karaman","year":"2017","journal-title":"Pain. Physician"},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3923\/jpt.2006.407.417","article-title":"Molecular Modelling Analysis of the Metabolism of Codeine","volume":"1","author":"Huq","year":"2006","journal-title":"J. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib66","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib67","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib68","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/cancers14092253","article-title":"Chronic Cancer Pain: Opioids within Tumor Microenvironment Affect Neuroinflammation, Tumor and Pain Evolution","volume":"14","author":"Santoni","year":"2022","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.prp.2026.156486_bib69","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","article-title":"Targeting the tumor microenvironment: from understanding pathways to effective clinical trials","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2026.156486_bib70","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1038\/srep11389","article-title":"Morphine Modulates Interleukin-4- or Breast Cancer Cell-induced Pro-metastatic Activation of Macrophages","volume":"5","author":"Khabbazi","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib71","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","article-title":"Mast cell activation contributes to sickle cell pathobiology and pain in mice","volume":"122","author":"Vincent","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib72","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bcp.2006.07.032","article-title":"NF-kappaB in solid tumors","volume":"72","author":"Pacifico","year":"2006","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.prp.2026.156486_bib73","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2147\/JIR.S451455","article-title":"Effect of Intraoperative Opioid Dose on Perioperative Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Glioma","volume":"17","author":"Liu","year":"2024","journal-title":"J. Inflamm. Res"},{"issue":"12","key":"10.1016\/j.prp.2026.156486_bib74","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.5414\/CP202190","article-title":"Effects of postoperative analgesia with the combination of tramadol and lornoxicam on serum inflammatory cytokines in patients with gastric cancer","volume":"52","author":"Sun","year":"2014","journal-title":"Int J. Clin. Pharm. Ther."},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib75","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.62347\/SCLS3277","article-title":"Impact of opioids and mu-opioid receptors on oncologic metastasis","volume":"14","author":"Wang","year":"2024","journal-title":"Am. J. Cancer Res"},{"issue":"1-2","key":"10.1016\/j.prp.2026.156486_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tox.2008.11.015","article-title":"Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways","volume":"256","author":"Hsiao","year":"2009","journal-title":"Toxicology"},{"issue":"1-2","key":"10.1016\/j.prp.2026.156486_bib77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1006431309841","article-title":"Nitric oxide and angiogenesis","volume":"50","author":"Ziche","year":"2000","journal-title":"J. Neurooncol"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cellimm.2010.08.002","article-title":"Chronic morphine treatment inhibits LPS-induced angiogenesis: implications in wound healing","volume":"265","author":"Martin","year":"2010","journal-title":"Cell Immunol."},{"issue":"1-2","key":"10.1016\/j.prp.2026.156486_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mvr.2006.04.004","article-title":"Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation","volume":"72","author":"Singleton","year":"2006","journal-title":"Micro Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib80","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajpath.2013.12.019","article-title":"Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice","volume":"184","author":"Koodie","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib81","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41429-022-00565-z","article-title":"Butorphanol inhibits angiogenesis and migration of hepatocellular carcinoma and regulates MAPK pathway","volume":"75","author":"Guo","year":"2022","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.prp.2026.156486_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109822","article-title":"M2 macrophage-derived exosomes induce angiogenesis and increase skin flap survival through HIF1AN\/HIF-1\u03b1\/VEGFA control","volume":"751","author":"Luo","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jvoice.2021.02.018","article-title":"Mu-Opioid Receptor Expression in Laryngeal Cancer","volume":"37","author":"Lahav","year":"2023","journal-title":"J. Voice"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010134","article-title":"Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study","volume":"12","author":"D\u00edaz-Cambronero","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2005.04.006","article-title":"Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4","volume":"235","author":"Molteni","year":"2006","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib86","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jso.21392","article-title":"Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4\/MyD88 signaling pathway","volume":"100","author":"Ikebe","year":"2009","journal-title":"J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib87","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","article-title":"Evidence that opioids may have toll-like receptor 4 and MD-2 effects","volume":"24","author":"Hutchinson","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.prp.2026.156486_bib89","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbi.2016.12.002","article-title":"Activation of \u03bc-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice","volume":"61","author":"Xie","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib90","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/bph.12028","article-title":"Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4","volume":"168","author":"Stevens","year":"2013","journal-title":"Br. J. Pharm."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib91","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","article-title":"FUNMarker: Fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers","volume":"18","author":"Li","year":"2020","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinforma."},{"key":"10.1016\/j.prp.2026.156486_bib92","article-title":"The effect of mitochondria inhibition on natural killer cells cytotoxicity in triple-negative breast cancer cells","volume":"960","author":"Khodaei","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib93","doi-asserted-by":"crossref","first-page":"e1574","DOI":"10.1634\/theoncologist.2019-0868","article-title":"Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer","volume":"25","author":"Shen","year":"2020","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib94","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/j.pain.0000000000001736","article-title":"Pain, opioid therapy, and survival: a needed discussion","volume":"161","author":"Novy","year":"2020","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib95","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-011-9285-0","article-title":"Morphine and tumor growth and metastasis","volume":"30","author":"Afsharimani","year":"2011","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib96","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/sj.bjc.6604057","article-title":"COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia","volume":"97","author":"Farooqui","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib97","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/bja\/aer259","article-title":"Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene","volume":"107","author":"Ecimovic","year":"2011","journal-title":"Br. J. Anaesth."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib98","first-page":"7708","article-title":"Effects of fentanyl anesthesia and sufentanil anesthesia on regulatory T cells frequencies","volume":"7","author":"Gong","year":"2014","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib99","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/00000542-200703000-00018","article-title":"High-dose morphine impairs vascular endothelial function by increased production of superoxide anions","volume":"106","author":"Lam","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.prp.2026.156486_bib100","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/bja\/aeu090","article-title":"Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer","volume":"113","author":"Nguyen","year":"2014","journal-title":"Br. J. Anaesth."},{"issue":"11","key":"10.1016\/j.prp.2026.156486_bib101","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0192-0561(99)00048-X","article-title":"Effects of tramadol and its enantiomers on Concanavalin-A induced-proliferation and NK activity of mouse splenocytes: involvement of serotonin","volume":"21","author":"Sacerdote","year":"1999","journal-title":"Int J. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib102","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1248\/bpb.b17-00215","article-title":"Morphine can inhibit the growth of breast cancer MCF-7 cells by arresting the cell cycle and inducing apoptosis","volume":"40","author":"Chen","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.prp.2026.156486_bib103","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fphys.2017.00510","article-title":"Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating \u03b11, 6-Fucosylation via Wnt\/\u03b2-Catenin Signaling Pathway","volume":"8","author":"Yang","year":"2017","journal-title":"Front Physiol."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib104","first-page":"735","article-title":"Fentanyl Inhibits Tumorigenesis from Human Breast Stem Cells by Inducing Apoptosis","volume":"18","author":"Kocak","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"14","key":"10.1016\/j.prp.2026.156486_bib105","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/febs.16768","article-title":"MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy","volume":"290","author":"Zhou","year":"2023","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib106","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193524","article-title":"The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells","volume":"40","author":"Yu","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.prp.2026.156486_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2024.100458","article-title":"Oxycodone enhances antitumor effect of paclitaxel on human breast cancer SKBR3 cells in vitro","volume":"79","author":"Liu","year":"2024","journal-title":"Clin. (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib108","first-page":"157","article-title":"Tramadol inhibits proliferation, migration and invasion via \u03b12-adrenoceptor signaling in breast cancer cells","volume":"20","author":"Xia","year":"2016","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib109","doi-asserted-by":"crossref","first-page":"22113","DOI":"10.1038\/s41598-021-01701-9","article-title":"Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib110","first-page":"5813","article-title":"Survival Analysis of Patients with Breast Cancer Undergoing a Modified Radical Mastectomy With or Without a Thoracic Paravertebral Block: a 5-Year Follow-up of a Randomized Controlled Trial","volume":"37","author":"Karmakar","year":"2017","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib111","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/EDE.0000000000000480","article-title":"Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence","volume":"27","author":"Cronin-Fenton","year":"2016","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib112","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/0284186X.2017.1407040","article-title":"Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database","volume":"57","author":"Cronin-Fenton","year":"2018","journal-title":"Acta Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib113","doi-asserted-by":"crossref","DOI":"10.2174\/0115680096391788250610080609","article-title":"Controversial role of opioids: From pain control to cancer recurrence in breast cancer","author":"Maqbool","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib114","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/jnci\/djy042","article-title":"Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index","volume":"110","author":"Desmedt","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib115","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1213\/ANE.0b013e3181d2ad07","article-title":"Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis","volume":"110","author":"Forget","year":"2010","journal-title":"Anesth. Analg."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib116","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy","volume":"153","author":"Romero","year":"2012","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib117","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2011.10.024","article-title":"Expression of the opioid growth factor\u2013opioid growth factor receptor axis in human ovarian cancer","volume":"124","author":"Fanning","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/ebm.2011.011321","article-title":"Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer","volume":"237","author":"Donahue","year":"2012","journal-title":"Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib119","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12871-022-01812-4","article-title":"Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid receptor-dependent activation of EGFR","volume":"22","author":"Xiao","year":"2022","journal-title":"BMC Anesthesiol."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib121","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomark. & Prev."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib122","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.vacune.2024.05.013","article-title":"A review on non-small cell lung cancer","volume":"25","author":"Verma","year":"2024","journal-title":"Vacunas (Engl. Ed. )"},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib123","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib124","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/JTO.0000000000000226","article-title":"Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004","volume":"9","author":"Takei","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non\u2013small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2026.156486_bib126","series-title":"Seminars in interventional radiology","article-title":"Radiation therapy for early stage lung cancer","author":"Parashar","year":"2013"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib127","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"Yuan","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/resp.12789","article-title":"Immunotherapy for lung cancer","volume":"21","author":"Steven","year":"2016","journal-title":"Respirology"},{"issue":"_1","key":"10.1016\/j.prp.2026.156486_bib129","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/bja\/aeu090","article-title":"Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer","volume":"113","author":"Nguyen","year":"2014","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2353\/ajpath.2010.090621","article-title":"Morphine suppresses tumor angiogenesis through a HIF-1\u03b1\/p38MAPK pathway","volume":"177","author":"Koodie","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.prp.2026.156486_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02334-8","article-title":"Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the MOR\/Src\/mTOR pathway","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.prp.2026.156486_bib132","article-title":"Giant Renal Cell Carcinoma (RCC): A Case Report of Delayed Diagnosis and Management","volume":"15","author":"Villacreses","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib133","first-page":"1","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib134","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/1078-0432.CCR-23-1892","article-title":"Management of Renal Cell Carcinoma: Promising Biomarkers and the Challenges to Reach the Clinic","volume":"30","author":"Lyskj\u00e6r","year":"2024","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/0886022X.2016.1256322","article-title":"Morphine enhances renal cell carcinoma aggressiveness through promotes survivin level","volume":"39","author":"Ma","year":"2017","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib136","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/0008-5472.CAN-20-1852","article-title":"Identifying clear cell renal cell carcinoma coexpression networks associated with opioid signaling and survival","volume":"81","author":"Scarpa","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib137","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13046-024-03164-y","article-title":"Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib138","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41598-023-32627-z","article-title":"Ketorolac modulates Rac-1\/HIF-1\u03b1\/DDX3\/\u03b2-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma","volume":"13","author":"Sonawane","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib139","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/life13051196","article-title":"Extended Opioid Exposure Modulates the Molecular Metabolism of Clear Cell Renal Cell Carcinoma","volume":"13","author":"Garige","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.prp.2026.156486_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharm. Res"},{"issue":"7","key":"10.1016\/j.prp.2026.156486_bib141","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the treatment of glioblastoma multiforme\u2014A literature review and clinical outcomes","volume":"31","author":"Jezierza\u0144ski","year":"2024","journal-title":"Curr. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156486_bib142","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1227\/NEU.0000000000001036","article-title":"Timing of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients","volume":"78","author":"Wang","year":"2016","journal-title":"Neurosurgery"},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib143","article-title":"Current trends in the surgical management and treatment of adult glioblastoma","volume":"3","author":"Young","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib144","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomark. & Prev."},{"key":"10.1016\/j.prp.2026.156486_bib145","article-title":"Kappa opioid receptor internalisation-induced p38 nuclear translocation suppresses glioma progression","author":"Li","year":"2024","journal-title":"Br. J. Anaesth."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib146","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.peptides.2010.05.002","article-title":"A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro","volume":"31","author":"Lazarczyk","year":"2010","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib147","first-page":"295","article-title":"Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43\u2011mediated gap junction intercellular communication","volume":"52","author":"Wang","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib148","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s11064-019-02837-x","article-title":"Noscapine, a non-addictive opioid and microtubule-inhibitor in potential treatment of glioblastoma","volume":"44","author":"Altinoz","year":"2019","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib149","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.7150\/ijbs.78535","article-title":"The emerging role of super-enhancers as therapeutic targets in the digestive system tumors","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156486_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2023.101839","article-title":"Colorectal cancer: A health and economic problem","volume":"66","author":"Klimeck","year":"2023","journal-title":"Best. Pract. & Res. Clin. Gastroenterol."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-025-02869-0","article-title":"Role of Tigecycline in radiation sensitivity in colorectal cancer cell line","volume":"42","author":"Hassanpour Khodaei","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib152","article-title":"Molecular Network of Colorectal Cancer and Current Therapeutic Options","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114014","article-title":"Toosendanin-induced apoptosis in colorectal cancer cells is associated with the \u03ba-opioid receptor\/\u03b2-catenin signaling axis","volume":"177","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib154","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJMoa0808268","article-title":"Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer","volume":"360","author":"Tol","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9863","key":"10.1016\/j.prp.2026.156486_bib155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Grothey","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156486_bib156","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.3502","article-title":"Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC)","author":"Bendell","year":"2016","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.prp.2026.156486_bib157","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib158","first-page":"72","article-title":"The role of EGFR monoclonal antibodies (MoABs) cetuximab\/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer","volume":"4","author":"Muhammad","year":"2013","journal-title":"J. Gastrointest. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib159","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1002\/jcp.30161","article-title":"Morphine promotes tumorigenesis and cetuximab resistance via EGFR signaling activation in human colorectal cancer","volume":"236","author":"Lu","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib160","first-page":"227","article-title":"Fentanyl inhibits proliferation and invasion of colorectal cancer via \u03b2-catenin","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib161","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2015.08.068","article-title":"Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets-1 on BANCR","volume":"465","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"10.1016\/j.prp.2026.156486_bib162","doi-asserted-by":"crossref","first-page":"10015","DOI":"10.7314\/APJCP.2014.15.22.10015","article-title":"Fentanyl increases colorectal carcinoma cell apoptosis by inhibition of NF-\u03baB in a Sirt1-dependent manner","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2026.156486_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144030","article-title":"The effects of tramadol on cancer stem cells and metabolic changes in colon carcinoma cells lines","volume":"718","author":"\u00d6zg\u00fcrb\u00fcz","year":"2019","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib164","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib165","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3748\/wjg.v29.i6.1054","article-title":"Immunotherapy for hepatocellular carcinoma: Current status and future perspectives","volume":"29","author":"Mandlik","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"3-4","key":"10.1016\/j.prp.2026.156486_bib166","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000343828","article-title":"Treatment of hepatocellular carcinoma: a systematic review","volume":"1","author":"Lin","year":"2012","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib167","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3892\/mmr.2014.2301","article-title":"Activated \u03b4\u2011opioid receptors inhibit hydrogen peroxide\u2011induced apoptosis in liver cancer cells through the PKC\/ERK signaling pathway","volume":"10","author":"Jia","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib168","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.bja.2018.09.030","article-title":"The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target","volume":"122","author":"Chen","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"12","key":"10.1016\/j.prp.2026.156486_bib169","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.prp.2026.156486_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.03.038","article-title":"The \u03bc-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma","volume":"453","author":"Li","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156486_bib171","article-title":"Morphine suppresses liver cancer cell tumor properties in vitro and in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib172","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1007\/s00210-023-02871-1","article-title":"Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment","volume":"397","author":"Wang","year":"2024","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib173","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12032-025-03125-1","article-title":"Combined Inhibition of telomerase and mitochondria synergistically promote apoptosis in AML cell lines","volume":"43","author":"Kalarestaghi","year":"2026","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib174","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2017.06.058","article-title":"Application of aptamers in treatment and diagnosis of leukemia","volume":"529","author":"Yazdian-Robati","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.prp.2026.156486_bib175","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/cncr.11316","article-title":"Trends in leukemia incidence and survival in the United States (1973-1998)","volume":"97","author":"Xie","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib176","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/fcp.12581","article-title":"Fentanyl inhibits acute myeloid leukemia differentiated cells and committed progenitors via opioid receptor-independent suppression of Ras and STAT5 pathways","volume":"35","author":"Dai","year":"2021","journal-title":"Fundam. & Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib177","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.bbrc.2020.10.031","article-title":"Oxycodone stimulates normal and malignant hematopoietic progenitors via opioid-receptor-independent-\u03b2-catenin activation","volume":"533","author":"Hu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6B","key":"10.1016\/j.prp.2026.156486_bib178","first-page":"4037","article-title":"Effect of anticancer agents on codeinone-induced apoptosis in human cancer cell lines","volume":"25","author":"Takeuchi","year":"2005","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib179","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ejp.1506","article-title":"The effects of long-term opioid treatment on the immune system in chronic non-cancer pain patients: A systematic review","volume":"24","author":"Diasso","year":"2020","journal-title":"Eur. J. Pain."},{"issue":"6673","key":"10.1016\/j.prp.2026.156486_bib180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.prp.2026.156486_bib181","doi-asserted-by":"crossref","first-page":"10225","DOI":"10.1074\/jbc.M110.188680","article-title":"Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib182","article-title":"Assessment of L-carnitine as a therapeutic agent for cancer-related fatigue in patients receiving platinum-based chemotherapy regimens; a parallel-group, randomized, double-blind clinical trial study","volume":"11","author":"Delkash","year":"2026","journal-title":"J. Prev. Epidemiol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib183","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.surg.2005.07.009","article-title":"The effect of morphine on mast cell\u2013mediated mucosal permeability","volume":"139","author":"Harari","year":"2006","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib184","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/pme.12784","article-title":"MicroRNA-873 inhibits morphine-induced macrophage apoptosis by elevating A20 expression","volume":"16","author":"Li","year":"2015","journal-title":"Pain. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bph.12589","article-title":"Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis","volume":"172","author":"Afsharimani","year":"2015","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib186","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00210-011-0672-4","article-title":"The role of morphine in regulation of cancer cell growth","volume":"384","author":"Gach","year":"2011","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.prp.2026.156486_bib187","article-title":"Research progress on the effects of opioids on the immune system","author":"Lei","year":"2024","journal-title":"Trends Anaesth. Crit. Care"},{"issue":"14","key":"10.1016\/j.prp.2026.156486_bib188","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system\u2013friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib189","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/bja\/aet153","article-title":"Opioids and immune modulation: more questions than answers","volume":"111","author":"Al-Hashimi","year":"2013","journal-title":"Br. J. Anaesth."},{"issue":"1-3","key":"10.1016\/j.prp.2026.156486_bib190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/00207459108985455","article-title":"Evaluation of NK and LAK cell activities in neoplastic patients during treatment with morphine","volume":"59","author":"Provinciali","year":"1991","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib191","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0192-0561(96)00059-8","article-title":"Role of prolactin in the modulation of NK and LAK cell activity after short-or long-term morphine administration in neoplastic patients","volume":"18","author":"Provinciali","year":"1996","journal-title":"Int. J. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib192","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth. & Analg."},{"key":"10.1016\/j.prp.2026.156486_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-021-02784-8","article-title":"The role of opioids in cancer response to immunotherapy","volume":"19","author":"Botticelli","year":"2021","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib194","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/jpm.2018.0044","article-title":"Opioid dose and survival of patients with incurable nonsmall cell lung cancer: a prospective cohort study","volume":"21","author":"Hasegawa","year":"2018","journal-title":"J. Palliat. Med."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/COC.0000000000000714","article-title":"Impact of pain, opioids, and the mu-opioid receptor on progression and survival in patients with newly diagnosed stage IV pancreatic cancer","volume":"43","author":"Steele","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156486_bib196","first-page":"2259","article-title":"Impact of opioid use on health care utilization and survival in patients with newly diagnosed stage IV malignancies","volume":"26","author":"Zylla","year":"2018","journal-title":"Support. Care Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib197","doi-asserted-by":"crossref","DOI":"10.1177\/1073274819871326","article-title":"Association of opioid use in the week before death among patients with advanced lung cancer having sepsis","volume":"26","author":"Choi","year":"2019","journal-title":"Cancer Control"},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib198","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272142","article-title":"Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012\u20132019","volume":"17","author":"Bandara","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib200","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzm\u00e1n","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib201","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/0008-5472.CAN-07-2785","article-title":"Cannabinoids for cancer treatment: progress and promise","volume":"68","author":"Sarfaraz","year":"2008","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2026.156486_bib202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2006.03.005","article-title":"The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells","volume":"9","author":"Carracedo","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellsig.2004.05.011","article-title":"Cannabinoids down-regulate PI3K\/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein","volume":"17","author":"Ellert-Miklaszewska","year":"2005","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjc.6603236","article-title":"A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme","volume":"95","author":"Guzm\u00e1n","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"51","key":"10.1016\/j.prp.2026.156486_bib205","doi-asserted-by":"crossref","first-page":"39480","DOI":"10.1074\/jbc.M603495200","article-title":"Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1\/2 leading to G1 cell cycle arrest","volume":"281","author":"Sarfaraz","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.10190","article-title":"Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production","volume":"56","author":"Mimeault","year":"2003","journal-title":"Prostate"},{"issue":"13","key":"10.1016\/j.prp.2026.156486_bib207","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1158\/0008-5472.CAN-06-0169","article-title":"Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes","volume":"66","author":"Carracedo","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib208","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","article-title":"Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level","volume":"50","author":"Gunaydin","year":"2018","journal-title":"Eurasia J. Med"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib209","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mpaic.2010.10.022","article-title":"Non-opioid analgesics","volume":"12","author":"Hebbes","year":"2011","journal-title":"Anaesth. & Intensive Care Med."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1742-1241.2007.01668.x","article-title":"NSAIDs and breast cancer: a possible prevention and treatment strategy","volume":"62","author":"Agrawal","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib211","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. & Pharm. Sci."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib212","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1572-0241.2002.05528.x","article-title":"NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action","volume":"97","author":"Husain","year":"2002","journal-title":"Off. J. Am. Coll. Gastroenterol. | ACG"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib213","article-title":"Association between metabolic syndrome and risk of endometrial cancer; a systematic review and meta-analysis","volume":"11","author":"Abbasi","year":"2024","journal-title":"Immunopathol. Persa"},{"key":"10.1016\/j.prp.2026.156486_bib214","first-page":"695","article-title":"Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?","volume":"23","author":"Shinde","year":"2015","journal-title":"Support. Care Cancer"},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib215","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/clpt.1988.209","article-title":"The combination of ibuprofen and oxycodone\/acetaminophen in the management of chronic cancer pain","volume":"44","author":"Stambaugh","year":"1988","journal-title":"Clin. Pharmacol. & Ther."},{"key":"10.1016\/j.prp.2026.156486_bib216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0406-y","article-title":"Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer","volume":"6","author":"Pennock","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2026.156486_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2021.109326","article-title":"Ibuprofen-derived fluorescence inhibitor of COX-2 for breast cancer imaging, prevention and treatment","volume":"190","author":"Xia","year":"2021","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.prp.2026.156486_bib218","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1007\/s13277-014-2952-3","article-title":"Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell","volume":"36","author":"Akrami","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2026.156486_bib219","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00432-019-02902-6","article-title":"Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer","volume":"145","author":"Zhang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djaa114","article-title":"Effect of aspirin on cancer incidence and mortality in older adults","volume":"113","author":"McNeil","year":"2021","journal-title":"JNCI J. Nat. Cancer Institute"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib221","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2011.01.012","article-title":"Targeting apoptosis pathways by Celecoxib in cancer","volume":"332","author":"Jendrossek","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156486_bib222","series-title":"Proceedings","article-title":"Anti-Cancer Acitivity of Etodolac and Its Derivatives on Prostate and Colorectal Cancer Cell Lines","author":"Sevin\u00e7","year":"2018"},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib223","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41416-021-01259-3","article-title":"A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma","volume":"124","author":"Twelves","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228909","article-title":"Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro","volume":"15","author":"Milian","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/pcan.2016.19","article-title":"The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells","volume":"19","author":"Morell","year":"2016","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2","key":"10.1016\/j.prp.2026.156486_bib226","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2014.07.014","article-title":"Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1","volume":"92","author":"Haustein","year":"2014","journal-title":"Biochem Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib227","first-page":"6","article-title":"A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels","volume":"25","author":"Seya","year":"2011","journal-title":"J. Pain. Palliat. Care Pharm."},{"issue":"8","key":"10.1016\/j.prp.2026.156486_bib228","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s12630-022-02273-6","article-title":"The other opioid crisis: the situation in low-resource countries","volume":"69","author":"Roques","year":"2022","journal-title":"Can. J. Anesth. \/J. Can. D. 'Anesth. \u00e9sie"},{"issue":"10128","key":"10.1016\/j.prp.2026.156486_bib229","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","article-title":"Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report","volume":"391","author":"Knaul","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.prp.2026.156486_bib230","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1213\/ANE.0000000000004742","article-title":"Addressing the challenge of pain education in low-resource countries: essential pain management in Papua New Guinea","volume":"130","author":"Marun","year":"2020","journal-title":"Anesth. Analg."},{"issue":"3","key":"10.1016\/j.prp.2026.156486_bib231","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12630-016-0805-9","article-title":"Access to controlled medicines for anesthesia and surgical care in low-income countries: a narrative review of international drug control systems and policies","volume":"64","author":"Nickerson","year":"2017","journal-title":"Can. J. Anesth."},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib232","first-page":"59","article-title":"Potent analgesics are more expensive for patients in developing countries: a comparative study","volume":"18","author":"De Lima","year":"2004","journal-title":"J. Pain. Palliat. Care Pharm."},{"key":"10.1016\/j.prp.2026.156486_bib233","article-title":"A scoping review of opioid harm reduction interventions for equity-deserving populations","volume":"12","author":"Milaney","year":"2022","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.prp.2026.156486_bib234","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"Organization","year":"2018"},{"issue":"10","key":"10.1016\/j.prp.2026.156486_bib235","doi-asserted-by":"crossref","DOI":"10.2196\/31173","article-title":"A personalized, interactive, cognitive behavioral therapy\u2013based digital therapeutic (MODIA) for adjunctive treatment of opioid use disorder: development study","volume":"8","author":"Meyer","year":"2021","journal-title":"JMIR Ment. Health"},{"issue":"1","key":"10.1016\/j.prp.2026.156486_bib236","first-page":"50","article-title":"Solving the global opioid crisis: incorporating genetic addiction risk assessment with personalized dopaminergic homeostatic therapy and awareness integration therapy","volume":"8","author":"Zeine","year":"2024","journal-title":"J. Addict. Psychiatry"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:30:55Z","timestamp":1778747455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":236,"alternative-id":["S0344033826001391"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156486","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioids and cancer biology: Exploring the dark side of pain relief","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156486"}}